FibroGen Inc (FGEN)
1.30
+0.02
(+1.56%)
USD |
NASDAQ |
May 24, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
FibroGen Shares Outstanding: 99.48M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.48M |
| April 08, 2024 | 99.47M |
| March 31, 2024 | 99.47M |
| January 31, 2024 | 98.77M |
| December 31, 2023 | 98.77M |
| October 31, 2023 | 98.34M |
| September 30, 2023 | 98.34M |
| July 31, 2023 | 98.21M |
| June 30, 2023 | 98.20M |
| April 30, 2023 | 97.58M |
| April 10, 2023 | 96.70M |
| March 31, 2023 | 96.62M |
| January 31, 2023 | 94.18M |
| December 31, 2022 | 94.17M |
| October 31, 2022 | 93.96M |
| September 30, 2022 | 93.94M |
| July 31, 2022 | 93.74M |
| June 30, 2022 | 93.73M |
| April 30, 2022 | 93.30M |
| April 18, 2022 | 93.29M |
| March 31, 2022 | 93.29M |
| January 31, 2022 | 93.00M |
| December 31, 2021 | 92.88M |
| October 31, 2021 | 92.71M |
| September 30, 2021 | 92.71M |
| Date | Value |
|---|---|
| July 31, 2021 | 92.62M |
| June 30, 2021 | 92.61M |
| April 30, 2021 | 92.13M |
| March 31, 2021 | 92.08M |
| March 29, 2021 | 92.07M |
| January 31, 2021 | 91.56M |
| December 31, 2020 | 91.44M |
| October 31, 2020 | 91.01M |
| September 30, 2020 | 90.88M |
| July 31, 2020 | 90.36M |
| June 30, 2020 | 90.23M |
| April 30, 2020 | 89.10M |
| April 09, 2020 | 89.07M |
| March 31, 2020 | 88.90M |
| January 31, 2020 | 88.00M |
| December 31, 2019 | 87.66M |
| October 31, 2019 | 87.25M |
| September 30, 2019 | 87.21M |
| July 31, 2019 | 86.92M |
| June 30, 2019 | 86.85M |
| April 30, 2019 | 86.22M |
| April 09, 2019 | 86.15M |
| March 31, 2019 | 86.13M |
| January 31, 2019 | 85.56M |
| December 31, 2018 | 85.43M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
86.85M
Minimum
Jun 30 2019
99.48M
Maximum
Apr 30 2024
93.17M
Average
92.88M
Median
Dec 31 2021
Shares Outstanding Benchmarks
| Annovis Bio Inc | 11.17M |
| Emergent BioSolutions Inc | 52.40M |
| Vertex Pharmaceuticals Inc | 258.05M |
| Geron Corp | 593.13M |
| Nanoviricides Inc | 11.81M |